15 results
·
20ms
·
Sources: EU EUDAMED, US FDA
Filters
Regulation: Us FDA
×
KSEA UNIDRIVE II/II PLUS AND ENT ACCESSORIES
FDA 510(k)
FDA Class 2
·Ear, Nose, Throat
Uscan Sector Probe - Refurbished (Japan)
FDA UDI
ECHONOUS, INC.·09353278000403·Extracorporeal ultrasound imaging system transd...
Uscan Sector Probe (Japan)
FDA UDI
ECHONOUS, INC.·09369999064099·Extracorporeal ultrasound imaging system transd...
SCANLAN® Legacy Micro Forceps
FDA UDI
SCANLAN INTERNATIONAL INC·00846159033588·Legacy FRCP FH 1X2MT 1MM DD 9"
INSET
FDA Adverse Event
Malfunction
·UNOMEDICAL DEVICES S.A. DE C.V.·Product code FPA·January 20, 2026
BIPAP DUET LX BI-LEVEL SYSTEM
FDA 510(k)
FDA Class 2
·Anesthesiology
EEI SLUSH PAN DRAPE
FDA 510(k)
FDA Class 2
·General, Plastic Surgery
TE Ø 4.1MM RN, SLACTIVE® 10MM, TIZR, NTP
FDA Adverse Event
Injury
·INSTITUT STRAUMANN AG·Product code DZE·March 17, 2026
MINICAP
FDA Adverse Event
Injury
·BAXTER HEALTHCARE - CLEVELAND·Product code KDI·March 14, 2013
PRECISION®
FDA Adverse Event
Injury
·BOSTON SCIENTIFIC NEUROMODULATION·Product code LGW·March 1, 2011
IAB : 7.5 FR -30 CC
FDA Adverse Event
Injury
·ARROW INTL., INC.·Product code DSP·February 25, 2008
AUTOSOFT XC
FDA Adverse Event
Malfunction
·UNOMEDICAL A/S·Product code FPA·July 1, 2024
bk5000 Ultrasound System w/battery; Model No. 2300-61; System, Imaging, Pulsed Doppler, Ultrasonic
FDA Enforcement
Class II
·Ongoing·B-K Medical A/S·November 12, 2025
CADD-Solis Ambulatory Infusion Pumps, Model 2100. Intended for the following uses: Indicated for the following uses: Intra-arterial, subcutaneous, intraperitoneal, in close proximity to nerves, into an intraoperative site, epidural space or subarachnoid space. Therapies that require a continuous rate of infusion, intermittent bolus, and/or with patient-controlled demand doses.
FDA Enforcement
Class I
·Ongoing·Smiths Medical ASD Inc.·August 14, 2024
Quadra Assura, Model No. CD3265-40, CD3265-40Q, CD3365-40C, CD3365-40Q. Quadra Assura MP, Model No. CD3269-40, CD3269-40Q, CD3369-40C. Fortify and Fortify Assura implantable cardioverter defibrillators (ICDS) are intended to provided ventricular anti-tachycardia pacing and ventricular defibrillation for automated treatment of life threatening ventricular arrhythmias. The devices may also be programmed to provide single or dual chamber bradycardia pacing. Unify and Unify Assura cardiac resynchronization therapy defibrillators (CRTDs) are intended to provide ventricular anti-tachycardia pacing and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias. The devices may also be programmed to provide single or dual chamber bradycardia pacing, in additional to cardiac resynchronization therapy via left ventricular pacing
FDA Enforcement
Class I
·Terminated·St Jude Medical Inc.·November 2, 2016